// App-Quantinova.ai

: RISK OF CORONARY ARTERY DISEASE AND STROKE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS USING JAPANESE HEALTH INSURANCE DATABASE

Researchers

Presenter

  • Ryoko Sakai

Principal Investigators

  • Suguru Honda

  • Sho Suzuki

  • Masako Majima

  • Naoko Konda

  • Hideto Takada

  • Masayoshi Harigai

  • Hisashi Yamanaka

Medical Centers

  • Tokyo Medical University, Department of Radiology, Tokyo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Cardiovascular (CVS)

  • Autoimmune (AI)

Disease

  • Lupus

  • Coronary Artery Disease

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Mycophenolate mofetil

  • CKD-4101

  • Hydroxychloroquine

  • Methylprednisolone

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Mycophenolic acid

  • Oraprine

  • Methotrexate

  • Mizoribine

  • Tacrolimus

  • Belimumab

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Ayumi Pharmaceutical Co

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved